Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
269.9 USD | +0.21% | +0.37% | -6.28% |
05:03pm | Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe | MT |
03:38pm | Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.28% | 144B | |
+26.36% | 653B | |
+27.00% | 556B | |
-6.46% | 354B | |
+20.52% | 331B | |
+4.06% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-11.84% | 143B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- SVB Securities Initiates Amgen at Market Perform With $256 Price Target